Skip to main content
. 2020 Oct 14;9(10):993. doi: 10.3390/antiox9100993

Figure 5.

Figure 5

Viability was determined using MTT assay in T24 (A) and 253J B-V C-r (B) cells untreated (C, control) or treated with 8 µg/mL blank-GCD, 2.5 µg/mL CDDP, siNrf2-GCD (final concentrations 8 µg/mL GCD, 0.08 µM siNrf2), and siNrf2-GCD in combination with CDDP. Viability was measured at 24 h and 48 h. Results are expressed as percent of the relative control values and are the mean ± standard deviation of three separate experiments performed in triplicate. ** p < 0.01.